Brilinta Description

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Description

Brilinta 60 mg film-coated tablets: Round, biconvex, pink, marked with '60' above 'T' on one side and plain on the other.
Each film-coated tablet contains 60 mg ticagrelor.
Brilinta 90 mg film-coated tablets: Round, biconvex, yellow, marked with '90' above 'T' on one side and plain on the other.
Each film-coated tablet contains 90 mg ticagrelor.
Excipients/Inactive Ingredients: Brilinta 60 mg film-coated tablets: Tablet core: Mannitol (E421), Dibasic calcium phosphate, Magnesium stearate, Sodium starch glycolate, Hydroxypropyl-cellulose.
Tablet coating: Titanium dioxide (E171), Ferric oxide black (E172), Ferric oxide red (E172), Polyethylene glycol 400, Hydroxypropyl methylcellulose.
Brilinta 90 mg film-coated tablets: Tablet core: Mannitol (E421), Dibasic calcium phosphate, Magnesium stearate (E470b), Sodium starch glycolate, Hydroxypropyl-cellulose (E463).
Tablet coating: Talc, Titanium dioxide (E171), Ferric oxide yellow (E172), Polyethylene-glycol 400, Hypromellose (E464).

Manufacturer:

AstraZeneca

Distributor:

Zuellig

Four Star